Panthera appoints experienced non-executive director

Preston-based clinical trial site management specialist Panthera Biopartners has appointed M&A and fundraisings adviser Chris Steed as a non-executive director.

Chris has more than 25 years of experience as a corporate financier, working at Arthur Andersen, Deloitte and for the past 17 years as founder and managing partner of Argyll Partners.

He has acted as lead advisor on more than 125 transactions involving mergers and acquisitions and fundraisings on deals ranging from £4m to £300m. He works as a senior advisor, providing advice to shareholders and the boards of companies covering strategy and shareholder value creation.

Professor John Lyon, chairman of Panthera, said: "Chris's great experience will be invaluable to us as we continue to grow and build on the rapid expansion of the company.

"Since our launch in 2019, despite Covid, we will by the end of this year have extended our UK network to ten sites. We are now looking at overseas opportunities and intend with Chris’s help to become a significant global player."

  • For further Lancashire business news, advice and analysis subscribe to Lancashire Business View or join the LBV Hub from just £2.50 per month. Click here to subscribe now.